Eden will utilise Xinova’s unique “invention engine” to enhance and extend our core intellectual property portfolio and expand our technology base in areas outside of our current focus. Xinova’s global presence will also help us to increase our market presence outside Europe more efficiently and rapidly.
– Sean Smith, Eden CEO
To learn more about Eden
UK-based Eden Research partnered with Xinova and leveraged its global innovation network to expand Eden’s biocontrol technologies into new markets worldwide, along with access to elite expertise in business development, IP and licensing services. The agreement builds on natural synergies with Xinova’s leadership and expertise in agriculture, animal health, food ingredients, human health, and personal-care markets.
Eden Research, based in Gloucestershire, UK, developed a breakthrough method for using plant-produced biocidal chemicals (terpenes) as environmentally friendly pesticides and anti-microbial agents for consumer products. Before Eden’s novel technology, terpenes’ use has been restricted to the food flavoring, cosmetics, and pharmaceutical industries
Xinova continues to assist with expansion into new markets worldwide, particularly Asia, North America, and South America. Throughout the partnership, Xinova opens additional licensing opportunities for Eden from Xinova’s portfolio of IP assets. Eden may also improve and expand their own existing technologies and IP portfolio by engaging in co-development with Xinova’s curated global innovator collective.
Xinova engages with companies of all sizes to solve unique and tough problems.
Learn how we engage by clicking through the stories below.
PO Box #30873
Seattle, WA 98113
Xinova Japan GK
Yaesu Mitsui Building 6F
2-7-2 Yaesu, Chuo-ku
Tokyo 104-0028 Japan
10th floor, Golfzone Tower
Seoul 06072, Korea
+82 2 6952 8840
Erottajankatu 5 A 4
Affiliate offices in Tel Aviv & Vienna